Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 17, 2020 01:00 ET | Source: Sequana Medical

Sequana Medical Announces January 2021 Investor Conference Schedule

GHENT, Belgium, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart...
December 07, 2020 01:00 ET | Source: Sequana Medical

Sequana Medical to Host KOL Event on “The Challenge of Diuretic Resistance in the Management of Heart Failure Patients and the Potential for alfapump® DSR therapy”

Live webcast with Dr. Jeffrey Testani on 11 December 2020 at 03:00 pm CET / 09:00 am EST GHENT, Belgium, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels:...
November 19, 2020 02:00 ET | Source: Sequana Medical

Sequana Medical Announces Positive Interim Data From North American Pivotal alfapump® Study (POSEIDON)

Results from first 13 patients in Roll-In Cohort showed over 90% reduction in mean frequency of therapeutic paracentesis versus baselineIndication of rapid and persistent clinically relevant...
November 12, 2020 01:00 ET | Source: Sequana Medical

Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference

GHENT, Belgium, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart...
October 22, 2020 01:00 ET | Source: Sequana Medical

Sequana Medical Announces Strong Interim Results From RED DESERT alfapump® DSR Study and Provides Business Update

RED DESERT: Results from first five patients indicate repeated dose alfapump DSR therapy to be safe and effectiveInterim data support DSR hypothesis: kidneys eliminate free water to maintain...
October 15, 2020 01:00 ET | Source: Sequana Medical

Sequana Medical Appoints Two Additional Experts as Heart Failure Scientific Advisors

Dr. Felker and Dr. Udelson join current advisors to support the development of alfapump® DSR for the management of fluid overload in patients with heart failure GHENT, Belgium, Oct. 15, 2020 (GLOBE...
September 09, 2020 01:00 ET | Source: Sequana Medical

Sequana Medical announces September 2020 Investor Conference Schedule

GHENT, Belgium, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart...
September 03, 2020 01:00 ET | Source: Sequana Medical

Sequana Medical announces H1 2020 results and provides business update

POSEIDON – Implants in Canada continue; interim results expected H1 2021RED DESERT – Implants continue; interim results expected Q4 2020 DSR (Direct Sodium Removal) – Fundamental patents allowed in...
August 27, 2020 01:00 ET | Source: Sequana Medical

Sequana Medical Notice of 2020 Half Year Results and Business Update

GHENT, Belgium, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart...
July 28, 2020 01:00 ET | Source: Sequana Medical

Sequana Medical Announces €7.3 Million Debt Financing and Provides Clinical Update

Cash runway extended into H2 2021 enabling Sequana Medical to reach key near term value inflection pointsPOSEIDON – implants resumed and interim results expected in Q1 2021 (North American pivotal...